| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.09 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.09 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |